• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Andera Partners

EdRip's Saphymo sold to CNIM's Bertin

Bertin is former portfolio company of LBO France

  • Exits
  • 31 October 2014
EdRip backs Europ Net spinout

Firm invested via its €112m small-cap Cabestan fund

  • France
  • 22 October 2014
Maesa changes hands between EdRip funds

Tikehau provides unitranche facility to support deal

  • Buyouts
  • 14 October 2014
EdRip promotes two to partner

Promotions come weeks after firm closed €300m Winch Capital 3 fund

  • People
  • 14 October 2014
EdRip exits Groupe ADF after 7-year holding

Exit generates one of best performances by Winch fund, says EdRip

  • France
  • 07 October 2014
EdRip buys video codec developer TVN from FCDE

GP invests alongside company's management

  • Buyouts
  • 01 October 2014
VC-backed Probiodrug to list on Euronext

Consortium-backed biopharmaceutical company seeks funds for drug development

  • DACH
  • 26 September 2014
BPI France invests €10m in Poxel series-B extension

Company is backed by several VCs including EdRrip

  • France
  • 10 September 2014
EdRip closes Winch Capital 3 fund on €300m

Fund hits hard-cap after year on the road

  • Funds
  • 10 September 2014
EdRip et al. sell Sapiens in trade sale

Medtronics buys business in an all-cash transaction

  • Exits
  • 26 August 2014
VC-backed Supersonic raises €50m in IPO

Medical imaging specialist reaches €182.6m market cap

  • France
  • 10 April 2014
VC-backed Genticel lists on Euronext

IPO values business at €119.3m

  • France
  • 08 April 2014
VC-backed Supersonic aims for €60m IPO

Company is backed by VCs including EdRip and Omnes

  • Healthcare
  • 28 March 2014
EdRip, Sofinnova lead €18m round for Inotrem

Biomed Invest and Inserm Transfert Initiative also take part

  • France
  • 14 March 2014
Covagen extends series-B with Baxter investment

Swiss biotech Covagen has extended its CHF 42m series-B funding round, raised in December, to procure a further CHF 2.9m from Baxter Ventures.

  • DACH
  • 21 February 2014
EdRip's Cetal in OBO

Edmond de Rothschild Investment Partners (EdRip) has taken part in the owner buyout of its portfolio company Cetal, a French manufacturer of heating elements.

  • Buyouts
  • 04 February 2014
EdRip backs Groupe Gris

Edmond de Rothschild Investment Partners (EdRip) has invested in Groupe Gris, a French manufacturer of mechanical components, alongside historic backer ILP Sadepar.

  • France
  • 28 January 2014
EdRip hires new life sciences partner

Edmond de Rotschild Investment Partners (EdRip) has hired Dr Naveed Siddiqi as a partner in charge of the firm's Biodiscovery venture capital funds.

  • France
  • 09 January 2014
VC-backed Implanet floats

French medical technology company Implanet, backed by several venture capital firms, has listed on the NYSE Euronext Paris with a market cap of €39m.

  • France
  • 25 November 2013
Omnes-backed Exclusive Networks bolts on Secureway

Omnes Capital-backed Exclusive Networks Group, a French IT security software company, has acquired Dubai-based Secureway.

  • France
  • 20 November 2013
EdRip closes fourth life sciences fund on €192m

Edmond de Rothschild Investment Partners (EdRip) has held the final close of its fourth life sciences fund, BioDiscovery 4, on €192m.

  • Venture
  • 04 November 2013
ICG refinances Exclusive Networks

Intermediate Capital Group (ICG) has provided a senior debt package to refinance Omnes Capital-backed Exclusive Networks.

  • France
  • 26 September 2013
EdRip's fourth life sciences fund nears target

Edmond de Rothschild Investment Partners (EdRip) has so far raised €192m for its fourth life sciences fund, BioDiscovery 4, meaning the vehicle is close to reaching its target.

  • France
  • 16 August 2013
Gimv et al. back Jenavalve

A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.

  • DACH
  • 23 July 2013
567
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013